EPO and nonpapillary renal cell carcinoma: To examine the consequences of EPO exposure on ccRCC cells, we firstly treated 786-O and Caki-2 cells with a range of concentrations of exogenous r-Hu EPO (from 10 to 50 IU/mL) for 48 h and measured the relative cell viability using MTS assay.